AUMED participated in the 12th annual bacteriophage conference in Oxford, which is the only European phage conference with such a long tradition. The conference was focused on the research and application of bacteriophages in medicine, food industry and biotechnology. At the conference, AUMED presented ongoing research on Staphylococcus aureus bacteriophages in gel preparations for use in gynecology, implant application and surgery.
The conference was attended by research institutes specializing in the issue of bacteriophages from all over the world, which enabled AUMED to establish contact with new partners and develop cooperation with foreign research institutes.
Our subsidiary Aumed Pharma a.s. launches food supplement Gut Guard. Gut Guard probiotics contain a combination of 13 vital probiotic…
AUMED received support for the project “Development of an antibacterial preparation with phages for recurrent bacterial vaginosis”, registration number CZ.01.01.01/01/22_002/0000523….
AUMED received support for the project “Development of a new vaccine against Staphylococcus aureus”, registration number CZ.01.01.01/01/22_002/0000585. Staphylococcus aureus causes…
Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.
Ministry of Industry and Trade
Program TRIO
European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness
Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s
